ReporterX Fact Sheet
Learn how ReporterX, powered by NavaX, serves as an intelligent front-end patient data collection application, enabling reporters across the globe to leverage AI-assisted capabilities.
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Learn how ReporterX, powered by NavaX, serves as an intelligent front-end patient data collection application, enabling reporters across the globe to leverage AI-assisted capabilities.
In our checklist, we walk through the most important criteria to keep in mind when evaluating AI-driven data collection and reporting solutions.
Intensifying regulatory demands and rapidly growing analytical complexity ...
In our checklist, we outline the most important criteria that leading firms are keeping in mind to get the most out of AI and automation.
Watch ArisGlobal’s webinar to discover how organizations like yours are reimagining what’s possible with modern, AI-powered LifeSphere PV solutions designed specifically to empower pharma teams and future-proof their operations.
Watch ArisGlobal’s exclusive webinar where we explore how AI-powered regulatory technology is reshaping the way companies manage compliance, submissions, labeling, and regulatory intelligence.
Watch ArisGlobal’s exclusive webinar where we explore how AI-powered regulatory technology is reshaping the way companies manage compliance, submissions, labeling, and regulatory intelligence.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
In our checklist, we outline the most important criteria that leading firms are keeping in mind to get the most out of AI and automation.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved